Tofacitinib: Suppressing Tumor Invasion in Recurrent GBM Patients
Latest Information Update: 01 Jul 2025
At a glance
- Drugs Tofacitinib (Primary)
- Indications Glioblastoma; Glioma
- Focus Therapeutic Use
Most Recent Events
- 25 Jun 2025 Planned End Date changed from 1 Jun 2026 to 1 Jun 2027.
- 25 Jun 2025 Planned primary completion date changed from 1 Jun 2025 to 1 Jun 2026.
- 25 Jun 2025 Status changed from recruiting to active, no longer recruiting.